Neurology Department Kicks Off Year With Record Conference Accomplishments

Last month, faculty in the Department of Neurology presented their latest research findings at the 2017 International Stroke Conference in Houston, Texas. This marked the first conference of the year that the department presented at — but many more are on the horizon. Boasting a 100 percent abstract acceptance rate, a total of 22 research projects will be presented by the department between now and November 2017.

“Our faculty’s quality of work and dedication to the field of neurology is admirable; together, we seek to fulfill a vision of TTUHSC El Paso’s Department of Neurology becoming one of the nation’s premiere academic departments and the go-to place for neurological education, training and care,” said Salvador Cruz-Flores, M.D., M.P.H., chair of the department. “I am proud of what the department has accomplished and that we are being recognized both nationally and internationally for our hard work.”

The following abstracts were presented by researchers at last month’s International Stroke Conference:

• “Endovascular treatment for distal middle cerebral artery occlusions in patients with acute ischemic stroke from interventional management of stroke trial (IMS III)” – Mohammad Afzal, M.D.

• “Outcomes for intraccerebral hemorrhage patients with renal failure as comorbidity in the United States” – Mohammad Afzal, M.D.

• “The declaration of Santiago: A road map to improve stroke care in Latin America” – Salvador Cruz-Flores, M.D., M.P.H.

• “The middle cerebral artery occlusion, anatomy study and pitfalls in the design and classification of its segment occlusions in the clinical trials” –Arbaab Qureshi, M.D.

The following is a list of accepted publications and presentations that the Department of Neurology will share at upcoming conferences throughout the year.

The American Academy of Neurology’s 69th Annual Meeting
Boston, MA
April 22-28, 2017

• “Albumin neuroprotection in focal cerebral ischemia in humans: Another look at ALIAS trial subgroup” – Arbaab Qureshi, M.D.

• “Black tar heroin skin popping as a cause of botulism” – Ihtesham Qureshi, M.D.

• “Comparative analysis between vertebral and carotid dissections from a statewide inpatient data set” – Arbaab Qureshi, M.D.

• “Comparative analysis of in-hospital outcomes between spontaneous vertebral and carotid arterial dissection at a national level” – Gustavo Rodriguez, M.D.

• “Comparison of hospital utilization, hospital mortality and length of stay for patients in a persistent vegetative state across different racial groups” – Anantha Vellipuram, M.D.

• “Does the unruptured intracranial aneurysm treated score (UIATS) have a high risk of rupture threshold?” – Arbaab Qureshi, M.D.

• “Effect size of acute thrombectomy stroke trials: comparison of completed vs. terminated early” – Salvador Cruz-Flores, M.D., M.P.H.

• “Hospital utilization, length of stay and in-hospital mortality in patients with subarachnoid hemorrhage among different racial groups” – Arbaab Qureshi, M.D.

• “Implications of invasive vs. non-invasive blood pressure measurements in neurointerventional procedeures” – Sean Pauzauskie, M.D.

• “MCA sphenoidal segment (M1): Incidence of bifurcation within horizontal segment and relevance in mechanical thrombectomy” – Arbaab Qureshi, M.D.

• National trends in utilization of intravenous thrombolysis and endovascular treatment in acute ischemic stroke” – Anantha Vellipuram, M.D.

• “National utilization of IVIG, plasmapharesis or the combination in patients with Guillian-Barre Syndrome” – Darine Kassar, M.D.

• “Pre-existing renal failure increases in-hospital mortality in patients with intracerebral hemorrhage” – Arbaab Qureshi, M.D.

The 26th European Stroke Conference
Berlin, Germany
May 24-26, 2017

• “Traumatic vertebral and carotid artery dissections related to motor vehicle accidents. Injury characteristics and outcomes from a national inpatient sample” – Rakesh Khatri, M.D.

• “Does the unruptured intracranial aneurysm treated score (UIATS) have a high risk of rupture threshold?” – Paisith Piriyawat, M.D.

• “Impact of seizures and status epilepticus on hospital utilization, in-hospital mortality, palliative care, hospital charges and length of stay among intracerebral hemorrhage (ICH) patients” – Paisith Piriyawat, M.D.

• “Impact of seizures and status epilepticus on hospital utilization, in-hospital mortality, hospital charges and length of stay among subarachnoid hemorrhage (SAH) patients” – Paisith Piriyawat, M.D.

The 2017 6th World Intracranial Hemorrhage Conference
Baltimore, MD
May 1-3, 2017

• “Impact of seizures and status epilepticus on hospital utilization, in-hospital mortality, palliative care, hospital charges and length of stay among intracerebral hemorrhage (ICH) patients” – Mohammad Afzal, M.D.

• “Racial disparities on hospital utilization, hospital charges, and in-hospital and palliative care among patients with subarachnoid hemorrhage” – Mohammad Afzal, M.D.

• “Hospital utilization, in-hospital mortality, palliative care, hospital charges and length of stay for patients with intracerebral hemorrhage (ICH) across different racial groups” – Arbaab Qureshi, M.D.

• “Impact of seizures and status epilepticus on hospital utilization, in-hospital mortality, hospital charges and length of stay among subarachnoid hemorrhage (SAH) patients” – Arbaab Qureshi, M.D.